Institutional shares held 40.6 Million
33.5K calls
19.6K puts
Total value of holdings $425M
$350K calls
$205K puts
Market Cap $420M
39,107,800 Shares Out.
Institutional ownership 103.78%
# of Institutions 158


Latest Institutional Activity in ANGO

Top Purchases

Q2 2025
Divisadero Street Capital Management, LP Shares Held: 3.4M ($36.4M)
Q2 2025
Point72 Asset Management, L.P. Shares Held: 1.95M ($20.9M)
Q2 2025
Bastion Asset Management Inc. Shares Held: 959K ($10.3M)
Q2 2025
Bank Of America Corp Shares Held: 286K ($3.07M)
Q2 2025
Y Intercept (Hong Kong) LTD Shares Held: 225K ($2.41M)

Top Sells

Q2 2025
Armistice Capital, LLC Shares Held: 1.53M ($16.4M)
Q2 2025
Morgan Stanley Shares Held: 284K ($3.05M)
Q2 2025
Eam Investors, LLC Shares Held: 45K ($483K)
Q2 2025
Deutsche Bank Ag\ Shares Held: 28.2K ($302K)
Q2 2025
Envestnet Asset Management Inc Shares Held: 68.2K ($732K)

About ANGO

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.


Insider Transactions at ANGO

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
611K Shares
From 16 Insiders
Grant, award, or other acquisition 589K shares
Open market or private purchase 22.6K shares
Sell / Disposition
32.1K Shares
From 6 Insiders
Payment of exercise price or tax liability 28K shares
Open market or private sale 4.06K shares

Track Institutional and Insider Activities on ANGO

Follow ANGIODYNAMICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANGO shares.

Notify only if

Insider Trading

Get notified when an Angiodynamics Inc insider buys or sells ANGO shares.

Notify only if

News

Receive news related to ANGIODYNAMICS INC

Track Activities on ANGO